| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/01/2001 | EP1119611A1 Method for the treatment of chemonucleolysis |
| 08/01/2001 | EP1119584A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 08/01/2001 | EP1119581A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130 |
| 08/01/2001 | EP1119579A1 Antisense modulation of bcl-x expression |
| 08/01/2001 | EP1119376A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 08/01/2001 | EP1119371A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 08/01/2001 | EP1119370A1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 08/01/2001 | EP1119369A1 Vascular endothelial growth factor 3 |
| 08/01/2001 | EP1119368A2 Methods of modulating lipid metabolism and storage |
| 08/01/2001 | EP1119367A1 Method of using fetuin to induce apoptosis in cancer cells |
| 08/01/2001 | EP1119360A1 Methods and compositions for increasing intestinal absorption of fats |
| 08/01/2001 | EP1119352A1 A method for the treatment of ocular oxidative stress |
| 08/01/2001 | EP1119344A1 Method for prevention and/or cosmetic treatment of skin stripe and use in dermatology |
| 08/01/2001 | EP1119254A1 Novel treatment for stroke management |
| 08/01/2001 | EP1119253A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 08/01/2001 | EP1119252A2 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 08/01/2001 | EP1119251A1 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof |
| 08/01/2001 | EP0952823B1 Stabilized pharmaceutical compositions and process for the preparation thereof |
| 08/01/2001 | EP0806963B1 Carcinoma treatment |
| 08/01/2001 | EP0777489B1 Low molecular yeast active substance extract and process for preparing the same |
| 08/01/2001 | EP0760675B1 Compositions comprising dna damaging agents and p53 |
| 08/01/2001 | EP0740703B1 Diagnosis and treatment of infections due to streptococci and enterococci |
| 08/01/2001 | EP0737074B1 Botulinum toxins for treating hyperhydrosis |
| 08/01/2001 | EP0649434B1 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 08/01/2001 | EP0631503B1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306573A Novel human thrombopoietin mutein |
| 08/01/2001 | CN1306572A Soluble T cell receptor |
| 08/01/2001 | CN1306568A Human bile salt-stimulated lipase (BSSL) obtainable from transgenic sheep |
| 08/01/2001 | CN1306542A Moraxella catharralis proteins |
| 08/01/2001 | CN1306541A Compound for unstable dipeptidyl peptidase IV inhibitors |
| 08/01/2001 | CN1306540A Prodrugs of dipeptidyl peptidase IV inhibitors |
| 08/01/2001 | CN1306439A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 08/01/2001 | CN1306436A Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/01/2001 | CN1306435A Drugs contg. as active ingredient midkine or inhibitors thereof |
| 08/01/2001 | CN1306399A Additives for crustacean or fish feeds and feeds |
| 08/01/2001 | CN1306089A Structure and purification of venin-class thrombase for preventing and curing thrombotic diseases |
| 08/01/2001 | CN1306087A Method for culturing antibody gene enzyme |
| 08/01/2001 | CN1306007A Dry cell factor |
| 08/01/2001 | CN1305815A Hypoglycemic, antihypertensive and antisenility powder for dietotherapy and its preparing process |
| 08/01/2001 | CN1069062C Use of follicle-stimulating hormone |
| 08/01/2001 | CN1069061C Film for preventing and treating hyperplastic scar and prepn. method thereof |
| 08/01/2001 | CN1069060C Method of using active peptide in strengthening animal's immunity and as vaccine adjuvent |
| 07/31/2001 | USRE37302 Peptide |
| 07/31/2001 | US6268491 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 07/31/2001 | US6268488 Active therapeutic agent attached to blocking moiety that is sensitive to catalytic action of molecules having retro-aldol and retro-michael catalytic activity; targeted antitumor, cytotoxic and antibiotic therapy |
| 07/31/2001 | US6268486 Contacting mixture of polypeptide and impurities with specific monoclonal antibody so that binding occurs, desorbing polypeptide from antibody, and collecting polypeptide; immunoaffinity chromatography |
| 07/31/2001 | US6268485 Down-regulation resistant C3 convertase |
| 07/31/2001 | US6268483 Taking blood sample from patient, harvesting solution wich contains fibrin monomer, prothrombin, and factor xiii in certain concentrations, then forming fibrin polymer; for use in same patient |
| 07/31/2001 | US6268480 Amino acid sequence of interleukin-13bc protein; recombinant production; drug screening of binding inhibitors |
| 07/31/2001 | US6268479 Intracellular amyloid-beta peptide binding (ERAB) polypeptide |
| 07/31/2001 | US6268478 From new world primate and having specific vitamin d binding activity of at least 17,588-fold greater than endogenous protein; therapy and diagnosis of osteoporosis and hypercalcemia; drug screening |
| 07/31/2001 | US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents |
| 07/31/2001 | US6268476 EPH receptor ligands, and uses related thereto |
| 07/31/2001 | US6268474 Peptide antagonists of CGRP-receptor superfamily and methods of use |
| 07/31/2001 | US6268473 Amino acid sequences; muscle relaxants; treating benign essential blepharospasm and other forms of focal dystonia; antiwrinkle agents |
| 07/31/2001 | US6268472 Modified HGP-30 peptides, conjugates, compositions and methods of use |
| 07/31/2001 | US6268470 Nucleotide sequences; antitumor/anticarcinogenic agents; antisense agents; probes; recombinant host cells; gene therapy |
| 07/31/2001 | US6268411 Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 07/31/2001 | US6268350 Polynucleotides for inhibiting metastasis and tumor cell growth |
| 07/31/2001 | US6268349 Method for treating B19 parvovirus infections |
| 07/31/2001 | US6268348 That mimic the conformation necessary for recognition and docking of collagen binding species (such as cell surface receptors for collagen and fibronectin) and have the amino acid residues-ile-ala-folded in a beta-bend. |
| 07/31/2001 | US6268347 Alleviating neuropathic pain |
| 07/31/2001 | US6268346 Having high biological activity of the same type as the known natural compound bpc, but with shorter amino acid chains. |
| 07/31/2001 | US6268344 Associated with sepsis, purpura fulminans, meningococcal sepsis, bone marrow and other transplantations, severe burns, pregnancy, major surgery, severe trauma, or ards. |
| 07/31/2001 | US6268343 Derivatives of GLP-1 analogs |
| 07/31/2001 | US6268342 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/31/2001 | US6268341 These polypeptides are useful for treating diseases wherein antagonism of hupar is therapeutically beneficial. |
| 07/31/2001 | US6268340 In vivo regeneration of oligodendrocytes by bolus injection of NGFβ |
| 07/31/2001 | US6268338 Cyclohexapeptidyl amine compounds |
| 07/31/2001 | US6268337 Methods for treating vascular disorders using activated protein C |
| 07/31/2001 | US6268336 Pharmaceutical composition for treatment of hepatic diseases |
| 07/31/2001 | US6268335 Insoluble insulin compositions |
| 07/31/2001 | US6268334 Cells include cardiovascular cells, and the peptide may be delivered in a stent to treat or prevent restinosis. |
| 07/31/2001 | US6268216 Reagents and methods for the screening of compounds useful in the treatment of neurological diseases |
| 07/31/2001 | US6268214 Vectors encoding a modified low affinity nerve growth factor receptor |
| 07/31/2001 | US6268212 Tissue specific transgene expression |
| 07/31/2001 | US6268211 Transgene of complete human immunodeficiency virus genome except having 5'long terminal repeat, portion of 5'leader, and portion of 3' long terminal repeat deleted; also includes regulatory sequences for gene expression; animal models |
| 07/31/2001 | US6268207 Resolution of enantiomers from a mixture of (1r,2s)/(1s,2s)-1-amino-2-vinylcyclopropyl carboxylic acid methyl ester comprising the step of treating said mixture with an esterase to obtain the corresponding (1r,2s) enantiomer |
| 07/31/2001 | US6268194 A kinase protein that phosphorylates serine 32 and serine 36; understanding the inflammatory and immune response; drug screening |
| 07/31/2001 | US6268192 Delta 1-pyrroline-5-carboxylate reductase homolog |
| 07/31/2001 | US6268180 A nucleic acid encoding a polypeptide; production of biologically active interleukin |
| 07/31/2001 | US6268172 A polynucleotide encoding a polypeptide for histidine kinase; screening and development of antibiotics for streptococcal diseases; otitis media, conjunctivitis, pneumonia, bacteremia pleural empyema, menegitis, sinusitis |
| 07/31/2001 | US6268171 Recombinant PilC proteins, methods for producing them and their use |
| 07/31/2001 | US6268170 α-Tocopherol transport protein: compositions and methods |
| 07/31/2001 | US6268165 Methods for the early diagnosis of ovarian cancer |
| 07/31/2001 | US6268163 Identification of drug candidates modulating factor VII-mediated intracellular signaling |
| 07/31/2001 | US6268159 Visualizing tumor cells; administer radioactive particles to humans and detect positioning and accumulation of radioactive particles in body |
| 07/31/2001 | US6268151 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/31/2001 | US6268137 Phosphorothioate or phosphorodithioate linkages; cancer diagnosis |
| 07/31/2001 | US6268130 RP compositions and diagnostic uses therefor |
| 07/31/2001 | US6268122 Synthetically generated polypeptide which display hepatitis viral antigenicity; for use in the detection of viral infection and vaccine preparation |
| 07/31/2001 | US6268011 Mixture of soybean protein and soybean fiber |
| 07/31/2001 | US6267990 Preparation comprising initial dose of ace inhibitor optionally including excipient, first delayed-release pellet, in which active ingredient and optional excipient are covered with coating, second coated delayed-release pellet |
| 07/31/2001 | US6267981 Method of producing sustained-release preparation |
| 07/31/2001 | US6267973 Ectoin and ectoin derivatives as moisturizers in cosmetics |
| 07/31/2001 | US6267968 MDP derivatives and conjugates having haematipoietic function stimulating activity, and compositions containing same |
| 07/31/2001 | US6267965 Vectors for insertion and expression of foreign genes for use as safe immunization vehicles to elicit immune response against poxvius-ctyomegalovirus and human cytomegalovirus |
| 07/31/2001 | US6267964 Administering conjugate containing biologically active protein or peptide and polypeptide of bacterial origin that binds to serum albumin protein of mammalian origin; conjugate exhibiting enhanced in vivo half-life |
| 07/31/2001 | US6267960 Administering monoclonal antibody designated atcc no. hb-12612, hb-12616, atcc no. hb12618, or atcc no. hb-12617 which binds specifically to extracellular domain of prostate stem cell antigen (psca) to inhibit growth of prostate tumor |